| Model Number |
900SFC232 |
| Medical Device Problem Codes |
Insufficient Device Problem Information (3190); Patient Device Interaction Problem (4001); Intravalvular regurgitation (4068)
|
| Health Effect - Clinical Codes |
Dyspnea (1816); Tricuspid Valve Insufficiency/ Regurgitation (4453); Insufficient Information (4580)
|
| Date of Event |
12/09/2024
|
|
Type of Reportable Event
|
Death
|
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that post implant of this 32mm tricuspid annuloplasty product, the patient was hospitalized due to cardiac decompensation with dyspnea on exertion and orthopnea.An echocardiogram performed noted moderate to severe regurgitation.It was stated that medications were given.No additional adverse patient effects were reported.
|
| |
|
Event or Problem Description
|
|
Additional information was received that reported subsequently, 1 month later, the patient died.The cause of death was not received.Therefore, relatedness of the death to the annuloplasty ring could not be excluded.It is unknown whether an autopsy was performed.
|
| |
|
Additional Manufacturer Narrative
|
|
Updated data: b.2: outcome attributed to adverse event b.5: event description h.6: coding medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received that reported the cause of death as non-sudden cardiac death.No additional adverse patient effects were reported.
|
| |
|
Search Alerts/Recalls
|